Shares of Endo International surged as much as 18 percent after the company named a new CEO and projected upbeat full-year earnings. » Read More
United Therapeutics' Martine Rothblatt says investors with vision should get into her biotech firm now, before it grows to Google-like proportions.
U.S. insurers pay five times the cost of delivering a baby than do insurers in Spain, a study finds.
The new rates hikes are three times higher than the increases seen in the two most recent years.
Johnson & Johnson reported a 3.9 percent increase in second-quarter sales, helped by strength in its pharmaceuticals business.
Shares of Anthem, Cigna, Aetna and Humana fell after the DOJ is expected to file lawsuits to block their acquisition deals.
UnitedHealth reported a better-than-expected profit due to strength in its benefit management business, and technology and consulting divisions.
Workers will have between four and six health insurers, and five coverage levels to choose from on a new private exchange.
The new potential form of transmission underscores that the more we learn about Zika, the more concerned public health officials become.
Half of U.S. states have a 'high' or 'very high' prevalence of well water that's potentially corrosive enough to leach lead from pipes.
The former Retrophin CEO is accused of looting the company to pay off hedge fund investors he was suspected of defrauding.
An estimated 8 percent of Americans will be uninsured by 2025, when per capita health spending will top a projected $16,000.
There were no significant differences in the percentages of people getting or being offered health insurance through an employer.
Long after the impending Summer Olympics end, some countries are more likely to feel the after-effects than others.
Shares of Teva rose more than 3 percent Wednesday morning after it increased its second-quarter profit and revenue guidance.
The median deductible for a HealthCare.gov plan fell from $900 last year to $850 in 2016.
The deaths had come in the company's "ROCKET" trial for patients with relapsed or refractory B cell acute lymphoblastic leukemia.
Get the best of CNBC in your inbox